Standex International Corp/de/ (SXI) · Oct 30, 2026 · Earnings

Standex earnings beat as Electronics surges and FY27 outlook rises

Beat — Adjusted EPS $2.41 vs ~$2.34 consensus; revenue $232.6M vs ~$229.7M

Standex earnings beat revenue and adjusted EPS expectations, with record margins, strong orders, raised FY27 guidance, and a new $100 million buyback.

Standex is a diversified industrial manufacturer shifting its mix toward higher-growth electronics, electrification, data-center, defense, and other fast-growth applications while investing in new products and capacity. That strategy is now showing up in both demand and profitability, not just management commentary.

The quarter cleared expectations on both major earnings measures. Adjusted EPS was $2.41 versus published consensus of roughly $2.34, while revenue reached $232.6 million versus roughly $229.7 million expected. The outperformance was not dependent on a single accounting item: organic sales rose 12.4%, adjusted operating margin expanded 110 basis points, and order intake reached a record approximately $273 million.

Q1 FY27Q1 FY26Consensus
Revenue (Financial Highlights)$232.6M (+7.0%)$217.4M~$229.7M
Adjusted EPS (Financial Highlights)$2.41 (+21.1%)$1.99~$2.34
Adjusted operating margin (Financial Highlights)20.2% (+110 bps)19.1%
Order intake (Financial Highlights)$273M
Book-to-bill (Financial Highlights)1.17

Electronics is doing most of the strategic heavy lifting. The segment grew organically about 30%, with a 1.23 book-to-bill, as demand from electrification, data centers, and the electrical grid accelerated. Standex also said new-product sales grew 56% and fast-growth-market sales grew 25%, suggesting the growth is broadening beyond a simple cyclical rebound. 〔0〕

The outlook upgrade is the most important change to the standing story. Standex raised fiscal 2027 total-sales growth from mid-to-high single digits to high-single digits, now expects organic sales to increase by more than $100 million, and continues to forecast high-teens adjusted EPS growth. That is a genuine improvement versus the prior framework, supported by the record order book and an expected launch of more than 20 products. 〔1〕

The growth investment is becoming more capital-intensive, but the balance sheet still supports it. Fiscal 2027 capital expenditures are expected at $45 million to $55 million, primarily for Electronics Grid capacity, versus $25.2 million in fiscal 2026. Net leverage was 2.0x, and the board authorized a new $100 million repurchase program, replacing the roughly $23.5 million remaining under the prior authorization. The buyback adds capital-return flexibility, though the more consequential signal is that management is willing to fund capacity expansion while still returning capital.

Not every end market improved. Engraving & Hydraulics revenue fell 14.9% year over year, led by weakness in North American automotive, while operating cash flow and free cash flow declined modestly from the prior-year quarter. Those are real offsets, but they do not outweigh the combination of an earnings beat, stronger orders, margin expansion, and raised full-year expectations.

Bottom line: This is a meaningful upgrade to Standex’s operating story: the high-growth Electronics engine is accelerating, margins are expanding, and management raised the year’s framework. The quarter matters because the improvement is showing up in orders and guidance, not only in reported results.

What to watch next

Q1 earnings call, October 30

Original filing on SEC EDGAR

More Standex International Corp/de/ news

Standex earnings beat as Electronics surges and FY27 outlook rises | SXI Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.